Bausch + Lomb receives 510(k) clearance for Crystalsert 2.6 injector

Bausch + Lomb announced it received FDA 510(k) clearance for its Crystalsert 2.6 injector.

The injector is designed to assist IOL delivery through an incision as small as 2.6 mm and can be used for the entire diopter range of Crystalens AO and Trulign toric IOLs, according to a company release.

“The CI-26 injector includes several enhancements designed to assist IOL delivery through a smaller incision,” Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb, said in the release. “Surgeons already know the benefits of our Crystalens accommodating and Trulign toric lenses, and we are happy to provide them with a smaller incision option to deliver these benefits to their patients.”

The injector features a smooth, oval tip shape to allow for easy wound entry and help prevent tissue snagging, according to the company.

Bausch + Lomb announced it received FDA 510(k) clearance for its Crystalsert 2.6 injector.

The injector is designed to assist IOL delivery through an incision as small as 2.6 mm and can be used for the entire diopter range of Crystalens AO and Trulign toric IOLs, according to a company release.

“The CI-26 injector includes several enhancements designed to assist IOL delivery through a smaller incision,” Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb, said in the release. “Surgeons already know the benefits of our Crystalens accommodating and Trulign toric lenses, and we are happy to provide them with a smaller incision option to deliver these benefits to their patients.”

The injector features a smooth, oval tip shape to allow for easy wound entry and help prevent tissue snagging, according to the company.